Albuterol HFA 90 mcg/actuation inhaler — Membership Pricing

Related medications

Other medications associated with the same conditions in this catalog.

Also listed for Asthma

• Budesonide inhalation
• Montelukast
• Budesonide inhalation 90/180 mcg
• Montelukast 4/5/10 mg tabs

About Albuterol HFA 90 mcg/actuation inhaler

Albuterol HFA 90 mcg actuation inhaler is a vital medication for millions managing respiratory conditions like asthma and COPD, providing fast relief when every breath counts. At TheDrugClub, we believe essential medications should be affordable for everyone. ### Your Breath, Unrestricted: Understanding Albuterol HFA 90 mcg Actuation Inhaler

For individuals living with asthma, chronic obstructive pulmonary disease (COPD), or exercise-induced bronchospasm, the Albuterol HFA 90 mcg actuation inhaler is often a lifeline. This medication is a fast-acting bronchodilator, commonly known as a "rescue inhaler," designed to provide quick relief during sudden breathing difficulties. It's prescribed to alleviate symptoms like wheezing, shortness of breath, coughing, and chest tightness that can arise from these conditions, often preventing more severe respiratory distress. #### How Albuterol HFA Works to Open Your Airways

The science behind Albuterol HFA is straightforward yet incredibly effective. When you experience an asthma attack or COPD flare-up, the muscles around your airways tighten and become inflamed, narrowing the passages and making it difficult to breathe. Albuterol belongs to a class of drugs called beta-2 adrenergic agonists. Upon inhalation, it works by relaxing the smooth muscles surrounding the airways in your lungs. This relaxation causes the airways to widen, allowing air to flow more freely and making breathing much easier. The effects are typically felt within minutes, providing rapid relief that can last for several hours. #### The Cost of Breathing: Typical Costs of Albuterol HFA

Access to essential medications shouldn't be a financial burden, but the reality is that the cost of an Albuterol HFA 90 mcg actuation inhaler can vary significantly. Without insurance, a single inhaler can range anywhere from $50 to over $100, depending on the pharmacy and whether it's a generic or brand-name product. Even with insurance, co-pays can still be substantial, often ranging from $20 to $60 or more, adding up over time for those who rely on it regularly. These costs can be a significant barrier, forcing many to

The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.

What Albuterol HFA 90 mcg/actuation inhaler is approved for (FDA label)

Albuterol Sulfate Inhalation Aerosol is a beta 2 -adrenergic agonist indicated for: Treatment or prevention of bronchospasm in patients 4 years of age and older with reversible obstructive airway disease. ( 1.1 ) Prevention of exercise-induced bronchospasm in patients 4 years of age and older. ( 1.2 ) 1.1 Bronchospasm Albuterol Sulfate Inhalation Aerosol is indicated for the treatment or prevention of bronchospasm in patients 4 years of age and older with reversible obstructive airway disease. 1.2 Exercise-Induced Bronchospasm Albuterol Sulfate Inhalation Aerosol is indicated for the prevention of exercise-induced bronchospasm in patients 4 years of age and older.

Source: Read the full FDA label on DailyMed. Label effective date: August 6, 2026.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Dosage forms and strengths for Albuterol HFA 90 mcg/actuation inhaler (FDA label)

Albuterol Sulfate is an inhalation aerosol. Albuterol Sulfate Inhalation Aerosol is supplied as an 8.5 g/200 actuations pressurized aluminum canister with a green plastic actuator with a dose counter and yellow dust cap each in boxes of one. Each actuation delivers 120 mcg of albuterol sulfate from the canister valve and 108 mcg of albuterol sulfate from the actuator mouthpiece (equivalent to 90 mcg of albuterol base). Inhalation Aerosol: Each actuation delivers 108 mcg of albuterol sulfate from the actuator mouthpiece (equivalent to 90 mcg of albuterol base). Supplied in 8.5-g canister containing 200 actuations.

Source: FDA prescribing information (DailyMed). Set ID: 17858afa-dcdf-4612-b475-3b6baadfb639. SPL document ID: aabe1b11-7f84-4db3-9d05-0c79a4a88ba2. Label effective date: August 6, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Adverse reactions for Albuterol HFA 90 mcg/actuation inhaler (FDA label)

Use of Albuterol Sulfate may be associated with the following: Paradoxical bronchospasm [see Warnings and Precautions ( 5.1 ) ] Cardiovascular Effects [see Warnings and Precautions ( 5.4 ) ] Immediate hypersensitivity reactions [see Warnings and Precautions ( 5.6 ) ] Hypokalemia [see Warnings and Precautions ( 5.8 ) ] Most common adverse reactions (≥3.0% and >placebo) are headache, tachycardia, pain, dizziness, pharyngitis, and rhinitis. ( 6.1 ) To report SUSPECTED ADVERSE REACTIONS, contact Armstrong Pharmaceuticals, Inc. at 1-800-423-4136 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch . 6.1 Clinical Trials Experience A total of 1090 subjects were treated with Albuterol Sulfate Inhalation Aerosol, or with the same formulation of albuterol as in Albuterol Sulfate Inhalation Aerosol, during the worldwide clinical development program.

Source: FDA prescribing information (DailyMed). Set ID: 17858afa-dcdf-4612-b475-3b6baadfb639. SPL document ID: aabe1b11-7f84-4db3-9d05-0c79a4a88ba2. Label effective date: August 6, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Contraindications for Albuterol HFA 90 mcg/actuation inhaler (FDA label)

Albuterol Sulfate Inhalation Aerosol is contraindicated in patients with a history of hypersensitivity to albuterol and any other Albuterol Sulfate Inhalation Aerosol components. Rare cases of hypersensitivity reactions, including urticaria, angioedema, and rash have been reported after the use of albuterol sulfate [see Warnings and Precautions ( 5.6 ) ] . Hypersensitivity to albuterol and any other Albuterol Sulfate Inhalation Aerosol Components.

Source: FDA prescribing information (DailyMed). Set ID: 17858afa-dcdf-4612-b475-3b6baadfb639. SPL document ID: aabe1b11-7f84-4db3-9d05-0c79a4a88ba2. Label effective date: August 6, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Warnings and precautions for Albuterol HFA 90 mcg/actuation inhaler (FDA label)

Life-threatening paradoxical bronchospasm may occur. Discontinue Albuterol Sulfate Inhalation Aerosol immediately and treat with alternative therapy. ( 5.1 ) Need for more doses of Albuterol Sulfate Inhalation Aerosol than usual may be a sign of deterioration of asthma and requires reevaluation of treatment. ( 5.2 ) Albuterol Sulfate Inhalation Aerosol is not a substitute for corticosteroids. ( 5.3 ) Cardiovascular effects may occur. Use with caution in patients sensitive to sympathomimetic drugs and patients with cardiovascular or convulsive disorders. ( 5.4 , 5.7 ) Excessive use may be fatal. Do not exceed recommended dose. ( 5.5 ) Immediate hypersensitivity reactions may occur. Discontinue Albuterol Sulfate Inhalation Aerosol immediately. ( 5.6 ) Hypokalemia and changes in blood glucose may occur. ( 5.7 , 5.8 ) 5.1 Paradoxical Bronchospasm Albuterol Sulfate Inhalation Aerosol can produce paradoxical bronchospasm that may be life threatening.

Source: FDA prescribing information (DailyMed). Set ID: 17858afa-dcdf-4612-b475-3b6baadfb639. SPL document ID: aabe1b11-7f84-4db3-9d05-0c79a4a88ba2. Label effective date: August 6, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Drug interactions for Albuterol HFA 90 mcg/actuation inhaler (FDA label)

Other short-acting sympathomimetic aerosol bronchodilators should not be used concomitantly with Albuterol Sulfate Inhalation Aerosol. If additional adrenergic drugs are to be administered by any route, they should be used with caution to avoid deleterious cardiovascular effects. Other short-acting sympathomimetic aerosol bronchodilators and adrenergic drugs: May potentiate effect. ( 7 ) Beta-blockers: May decrease effectiveness of Albuterol Sulfate and produce severe bronchospasm. Patients with asthma should not normally be treated with beta-blockers. ( 7.1 ) Diuretics, or non-potassium sparing diuretics: May potentiate hypokalemia or ECG changes. Consider monitoring potassium levels. ( 7.2 ) Digoxin: May decrease serum digoxin levels. Consider monitoring digoxin levels. ( 7.3 ) Monoamine oxidase (MAO) inhibitors and tricyclic antidepressants: May potentiate effect of albuterol on the cardiovascular system.

Source: FDA prescribing information (DailyMed). Set ID: 17858afa-dcdf-4612-b475-3b6baadfb639. SPL document ID: aabe1b11-7f84-4db3-9d05-0c79a4a88ba2. Label effective date: August 6, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.